Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Professora Associada at Universidade Federal do Pará, Brazil

Dr. Marta Chagas Monteiro is a distinguished biomedical researcher specializing in microbiology, immunology, and pharmacology. She holds a CNPq 1D Productivity Scholarship and serves as a professor and research coordinator at the Federal University of Pará (UFPA), Brazil. With over two decades of experience, she has made significant contributions to understanding infectious diseases, immune responses, and drug development. Her collaborations span international institutions, including the University of São Paulo, Aston University, and the University of Shanghai. As a prolific researcher, she has authored over 100 high-impact publications and serves on the editorial boards of leading scientific journals. Dr. Monteiro is also an active mentor, shaping future scientists through postgraduate programs. Her expertise in oxidative stress, biomarkers, and xenobiotic toxicity has positioned her as a leading figure in biomedical research, earning her recognition from national and international funding agencies.

Professional Profile

Education

Dr. Monteiro earned her Ph.D. in Basic and Applied Immunology from the University of São Paulo in 2004, focusing on immune responses and cellular migration in infectious diseases. Prior to that, she completed her Master’s degree in the same field at USP in 2000, with research centered on parasitology and pharmacology. Her academic foundation was laid at the Federal University of Pará, where she obtained a bachelor’s degree in Medical Biology in 1997. Over the years, she has pursued numerous specialized training courses in pharmacology, immunology, and biomedicine, including programs on oxidative stress, epigenetics, and experimental pharmacology. Her continuous education reflects a commitment to interdisciplinary research, integrating immunopharmacology, microbiology, and biotechnology into her work. This extensive academic background has enabled her to make significant contributions to scientific advancements, particularly in the study of immune responses, biomarkers, and the pharmacological effects of drugs on infectious and neurodegenerative diseases.

Professional Experience

Dr. Monteiro is a professor and coordinator at the Faculty of Pharmacy at UFPA, where she leads the Laboratory of Oxidative Stress and Clinical Immunology. She is actively involved in postgraduate programs in pharmaceutical sciences, neuroscience, and pharmacology. Beyond academia, she serves as an expert evaluator for major funding organizations, including CNPq, SUS, and INEP. Her work also extends to international collaborations, with ongoing projects in partnership with institutions in Brazil, the UK, and China. Additionally, she is a consultant for over 15 research development agencies and a reviewer for more than 90 scientific journals. As part of her professional engagements, she has contributed to the development of new pharmacological treatments, diagnostic tools, and innovative technologies in immunology. Her leadership in academia and research has significantly impacted biomedical advancements, particularly in the areas of infectious disease management and pharmacological interventions.

Research Interests

Dr. Monteiro’s research focuses on microbiology, clinical immunology, and pharmacology, with a particular emphasis on biomarkers and immune responses in infectious diseases. She investigates the pharmacological activities of drugs and natural products, as well as their toxicological effects on human health. Her work extends to studying oxidative stress, inflammation, and xenobiotic-mediated toxicity, providing insights into the development of new therapeutic strategies. Additionally, she explores neurodegenerative, autoimmune, and parasitic diseases, including malaria, tuberculosis, leishmaniasis, and sepsis. Through her extensive research, she has contributed to advancements in immunopharmacology, helping to identify novel drug targets and therapeutic interventions. Her multidisciplinary approach, combining molecular biology, pharmacology, and biotechnology, has led to breakthroughs in disease diagnostics and treatment methodologies, further solidifying her reputation as a leading expert in biomedical sciences.

Awards and Honors

Dr. Monteiro has received numerous accolades in recognition of her contributions to biomedical research. She is a recipient of the prestigious CNPq 1D Productivity Scholarship, which highlights her excellence in scientific investigation. Her research has been funded by national and international agencies, reflecting the high impact of her work. She has also been recognized for her role as an editor and reviewer for top-tier journals, including Frontiers in Immunology and Oxidative Medicine and Cellular Longevity. Additionally, she has contributed to the scientific community as a consultant and evaluator for research projects funded by leading organizations. Her patents and published innovations in immunopharmacology and microbiology have further established her as a respected figure in the field. Through her dedication to research, teaching, and mentorship, she has made a lasting impact on the scientific landscape, earning widespread recognition for her contributions to global health and biomedical advancements.

Conclusion

Dr. Marta Chagas Monteiro is highly qualified for the Best Researcher Award due to her extensive contributions, leadership in microbiology and immunology, international collaborations, and significant research impact. Strengthening her translational research and public engagement could further enhance her profile, but overall, she is a strong candidate.

Publications Top Notes

  1. Monteiro, M.C., Quadros Gomes, B.A., Dos Santos, S.M., Gato, L.D.S., Coleman, M.D. (2025)

    • Alpha-Lipoic Acid Reduces Neuroinflammation and Oxidative Stress Induced by Dapsone in an Animal Model.

    • Journal: Nutrients

    • Citations: 0

  2. Monteiro, M.C., de Farias, E.C.F., Pavão Júnior, M.J.C., de Sales, S.C.D., Terreri, M.T.R.A. (2024)

    • Factors associated with mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a resource-poor setting.

    • Journal: Scientific Reports

    • Citations: 2

  3. Monteiro, M.C. (co-author), Dos Santos, É.R.Q., Pantoja, L.V.P.D.S., Farias, S.V., Maia, J.G.S., Maia, C.S. (2024)

    • Linalool-rich rosewood essential oil (Aniba rosaeodora Ducke) mitigates emotional and neurochemical impairments induced by ethanol binge-like exposure during adolescence in female rats.

    • Journal: Biomedicine and Pharmacotherapy

    • Citations: 0

  4. Monteiro, M.C., Navegantes-Lima, K.C., Gaspar, S.L.D.F., De, A.L., Sovrani, V. (2024)

    • Lipid Fraction from Agaricus brasiliensis as a Potential Therapeutic Agent for Lethal Sepsis in Mice.

    • Journal: Antioxidants

    • Citations: 0

  5. Monteiro, M.C. (co-author), de Farias, E.C.F., Nascimento, L.M.P.P., Pavão Júnior, M.J.C., Clemente, G., Terreri, M.T.R.A. (2024)

    • Plasma IL-17A is increased in patients with critical MIS-C and associated with in-hospital mortality.

    • Journal: Frontiers in Immunology

    • Citations: 0

  6. Monteiro, M.C., Matos-Sousa, J.M., Chemelo, V.S., Frazão, D.R., Lima, R.R. (2024)

    • Is there any association between the presence of biomarkers and apical periodontitis? A systematic review.

    • Journal: [No source information available]

    • Citations: 3

  7. Monteiro, M.C., Valois, F.P., Bezerra, K.C.A., da Costa Assunção, F.P., Machado, N.T. (2024)

    • Improving the Antioxidant Activity, Yield, and Hydrocarbon Content of Bio-Oil from the Pyrolysis of Açaí Seeds by Chemical Activation: Effect of Temperature and Molarity.

    • Journal: Catalysts

    • Citations: 1

  8. Monteiro, M.C., Meneses, C.C.F., de Sousa, P.R.M., Lima, K.C.N., Lameira, J. (2023)

    • Caffeic Acid-Zinc Basic Salt/Chitosan Nanohybrid Possesses Controlled Release Properties and Exhibits In Vivo Anti-Inflammatory Activities.

    • Journal: Molecules

    • Citations: 3

  9. Monteiro, M.C. (co-author), Camara, F.M.S., da Conceição, B.C., Cardoso, E.K.S., Maia, C.S., Fontes-Júnior, E.A. (2023)

    • Margaritaria nobilis L.f. (Phyllanthaceae) Ethanolic Extract: Low Acute Oral Toxicity and Antinociceptive Activity.

    • Journal: Pharmaceuticals

    • Citations: 1

  10. Monteiro, M.C. (co-author), Dorneles, G.P., Teixeira, P.C., Peres, A.L., Wendland, E.M., Romão, P.R.T. (2023)

  • Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients.

  • Journal: Journal of Molecular Medicine

  • Citations: 8

 

Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Petra University, Jordan

Dr. Dania Alhyari is an accomplished pharmaceutical sciences researcher and assistant professor with over a decade of experience in academia, research, and mentorship. Her expertise lies in drug formulation, permeability, solubility, and phytochemistry, with a strong focus on enhancing drug bioavailability and therapeutic efficacy. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, and a Master’s in Molecular Biology from the University of Ottawa, Canada. Throughout her career, she has been actively involved in teaching and research, currently serving as an Assistant Professor at Petra University, Jordan, where she mentors graduate students and leads research projects on novel drug delivery systems. Previously, she was a Postdoctoral Fellow at the University of Bradford, where she collaborated on interdisciplinary research and presented findings at international conferences. Dr. Alhyari has published extensively in reputed journals, contributing to advancements in pharmaceutical sciences. Her work emphasizes the integration of molecular biology with drug formulation to optimize therapeutic outcomes. She has also received recognition for her academic contributions, including invitations to speak at conferences and research grants for her studies. With a strong background in teaching, research, and international collaboration, Dr. Alhyari continues to make significant contributions to pharmaceutical innovation.

Professional Profile

Education

Dr. Dania Alhyari holds a strong academic background in pharmaceutical sciences and molecular biology, which has shaped her expertise in drug formulation and biopharmaceutical research. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, where she focused on drug permeability and solubility studies, developing innovative methodologies to enhance drug bioavailability. Her doctoral research involved interdisciplinary collaborations and was presented at several international conferences. Prior to her Ph.D., she completed a Master’s degree in Molecular Biology at the University of Ottawa, Canada, where she gained in-depth knowledge of biochemical and genetic interactions related to pharmaceutical applications. During her master’s studies, she engaged in extensive laboratory work, investigating drug interactions at the molecular level. Her academic journey began with a Bachelor’s degree in Pharmacy, where she developed a solid foundation in drug formulation, pharmacokinetics, and analytical techniques. Throughout her education, Dr. Alhyari actively participated in research projects, contributing to publications and advancing pharmaceutical knowledge. Her diverse educational background, spanning pharmacy, molecular biology, and pharmaceutical sciences, has provided her with a multidisciplinary perspective that enhances her research capabilities. With a commitment to scientific discovery, her education has been instrumental in shaping her career in academia and pharmaceutical research.

Professional Experience

Dr. Dania Alhyari has amassed extensive professional experience in pharmaceutical research and academia, contributing significantly to drug formulation, solubility, and permeability studies. She currently serves as an Assistant Professor at Petra University, Jordan, where she teaches advanced courses in pharmaceutics and pharmaceutical technology while mentoring graduate students in innovative drug delivery research. In this role, she leads research projects exploring novel drug formulations and collaborates with international experts to enhance pharmaceutical applications. Prior to this, she worked as a Postdoctoral Fellow at the University of Bradford, UK, where she developed cutting-edge methodologies for drug permeability and solubility studies. During her postdoctoral tenure, she mentored students, presented her findings at international conferences, and worked closely with interdisciplinary teams to advance pharmaceutical research. Earlier in her career, Dr. Alhyari served as a Research and Teaching Assistant at Petra University, where she played a key role in curriculum development, laboratory research, and student mentorship. She co-authored multiple research papers and contributed to the design of laboratory experiments that enhanced the university’s pharmaceutical research capabilities. Her professional journey reflects a strong balance between research, teaching, and leadership, positioning her as a key contributor to the advancement of pharmaceutical sciences and education.

Research interest

Dr. Dania Alhyari’s research interests lie at the intersection of drug formulation, permeability, solubility, and phytochemistry, with a focus on optimizing drug delivery systems for improved therapeutic outcomes. She is particularly interested in enhancing the bioavailability of pharmaceutical compounds by studying their physicochemical and biopharmaceutical properties. Her work explores innovative drug delivery mechanisms, including novel excipients, nanoformulations, and targeted drug transport to improve drug absorption and efficacy. Additionally, she investigates the role of natural compounds in pharmaceutical sciences, studying their antioxidant, anti-inflammatory, and bioavailability-enhancing properties. Through interdisciplinary collaborations, she integrates molecular biology techniques with pharmaceutical sciences to better understand drug interactions at the cellular and molecular levels. Dr. Alhyari is also passionate about the development of more efficient and patient-friendly pharmaceutical formulations, ensuring safer and more effective therapeutic interventions. Her research extends to the evaluation of drug-excipient interactions, solubility enhancement strategies, and the design of pharmaceutical formulations that cater to specific medical needs. By combining experimental research with advanced analytical techniques, she aims to contribute to the evolution of drug development and pharmaceutical innovation. Her research efforts have been recognized through publications in high-impact journals and presentations at international conferences.

Award & Honor

Dr. Dania Alhyari has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, research, and education. Her dedication to advancing drug formulation and delivery systems has earned her invitations to present her findings at prestigious international conferences, where she has been acknowledged for her innovative research. She has also secured research grants that have supported her studies in drug permeability, solubility enhancement, and pharmaceutical applications, further demonstrating the significance of her work. Throughout her academic career, she has been recognized for excellence in teaching and mentorship, guiding both undergraduate and graduate students in pharmaceutical research. Her contributions to scientific literature, including publications in high-impact journals, have been widely cited, highlighting the relevance of her research in the global pharmaceutical community. Additionally, she has collaborated with leading researchers from renowned institutions in the UK and Canada, receiving commendations for her interdisciplinary work in pharmaceutical sciences and molecular biology. Dr. Alhyari’s commitment to research excellence, innovation, and education continues to be acknowledged through various accolades, reinforcing her position as a leading researcher in her field. Her achievements reflect her dedication to pushing the boundaries of pharmaceutical research and inspiring future scientists.

Conclusion

Dania Alhyari is a strong candidate for the Best Researcher Award due to her research output, international collaborations, and academic contributions. However, strengthening aspects like grant funding, patents, and research impact metrics would further solidify her case.

Publications Top Notes

  • Physicochemical and biopharmaceutical characterization of new sulfonamide derivatives of gallic acid

    • Author(s): D. Alhyari, H. Sheldrake, S. Kantamneni, M. Isreb, S.J. Soumehsaraei, et al.

    • Year: 2022

    • Citations: 4

  • Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid

    • Author(s): D. Alhyari, N.A. Qinna, H.M. Sheldrake, S. Kantamneni, B.Y. Ghanem, et al.

    • Year: 2025

    • Citations: Not available yet (recent publication)

  • Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid

    • Author(s): D.H. Alhyari

    • Year: 2022

    • Citations: Not available (Thesis/Dissertation)